Page 218 - Pagetit

6. CONCURRENT DISORDERS

Goff DC, Henderson DC, Amico E (1992) Cigarette smoking in schizophrenia:
relationship to psychopathology and medication side effects. American Journal
of Psychiatry, 149:1189–1194.
Goldman-Rakic PS (1995) Cellular basis of working memory. Neuron, 14:477–485.
Gonzalez P et al. (1997) Decrease of tolerance to, and physical dependence on,
morphine by glutamate receptor antagonists. European Journal of Pharmacology,
332:257–262.
Goodwin DW (1992) Alcohol: clinical aspects. In: Lowinson JH et al., eds.
Substance abuse: a comprehensive textbook, 2nd ed. Baltimore, MD, Williams &
Wilkins:144–151.
Grace AA (1995) The tonic/phasic model of dopamine system regulation: its
relevance for understanding how stimulant abuse can alter basal ganglia function.
Drug and Alcohol Dependence, 37:111–129.
Gray R et al. (1996) Hippocampal synaptic transmission enhanced by low
concentrations of nicotine. Nature, 383:713–716.
Green AI et al. (1999) Clozapine for comorbid substance use disorder and
schizophrenia: do patients with schizophrenia have a reward-deficiency
syndrome that can be ameliorated by clozapine? Harvard Review of Psychiatry,
6:287–296.
Green AR (1987) Evolving concepts on the interactions between antidepressant
treatments and monoamine neurotransmitters. Neuropharmacology, 26:815–822.
Griffith JD et al. (1972) Dextroamphetamine: evaluation of psychotomimetic
properties in man. Archives of General Psychiatry, 26:97–100.
Grillner P, Svensson TH (2000) Nicotine-induced excitation of mid-brain
dopamine neurons in vitro involves ionotropic glutamate receptor activation.
Synapse, 38:1–9.
Haertzen CA, Hooks NT Jr (1969) Changes in personality and subjective
experience associated with the chronic administration and withdrawal of opiates.
Journal of Nervous and Mental Disorders, 148:606–614.
Hall RG et al. (1995) Level of functioning, severity of illness, and smoking status
among chronic psychiatric patients. Journal of Nervous and Mental Disorders,
183:468–471.
Hambrecht M, Hafner H (1996) Substance abuse and the onset of schizophrenia.
Biological Psychiatry, 40:1155–1163.
Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in the
nucleus accumbens in the opiate withdrawal syndrome. Nature, 371:155–157.
Harrison AA, Liem YT, Markou A (2001) Fluoxetine combined with a serotonin-
1A receptor antagonist reversed reward deficits observed during nicotine and
amphetamine withdrawal in rats. Neuropsychopharmacology, 25:55–71.
Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with
schizophrenia following novel antipsychotic treatment. American Journal of
Psychiatry, 158:176–184.
Hazlett EA et al. (2000) Hypofrontality in unmedicated schizophrenia patients
studied with PET during performance of a serial verbal learning task.
Schizophrenia Research, 43:33–46.

197

Chapter_6 197 19.1.2004, 11:49